Clinical Trials on Metastatic Breast Cancer in Finland
Total 1406 results
-
Tampere University HospitalUniversity of Turku; University of Helsinki; Tampere University; Aalto UniversityRecruitingKidney Cancer | Breast Cancer | Metastatic Renal Cell Carcinoma | Ovarian Cancer | Prostate Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Ovarian Cancer | Metastatic Renal Cancer | Metastatic Kidney Cancer | Metastatic Ovary CancerFinland
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Side-Out FoundationTranslational Drug DevelopmentCompleted
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerFinland, Poland, Germany, United Kingdom, Belgium, Italy, Netherlands
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Roger Williams Medical CenterSuspendedMetastatic CancersUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Enzon Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
Helsinki University Central HospitalCompletedEarly Breast Cancer | Ambulatory Surgery | Psychosocial WellbeingFinland
-
R-PharmUS Oncology ResearchCompletedMetastatic Breast CancerUnited States
-
US Oncology ResearchBristol-Myers SquibbCompleted
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical LimitedCompleted
-
Finnish Breast Cancer GroupSanofi; Hoffmann-La Roche; AstraZenecaCompleted
-
Genentech, Inc.Completed
-
Turku University HospitalRecruiting
-
Helsinki University Central HospitalActive, not recruiting
-
Tampere University HospitalTurku University Hospital; Oulu University HospitalTerminated
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States, Spain, Poland, Ukraine
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Eli Lilly and CompanyWithdrawnMetastatic Breast CancerUnited States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
University of JyvaskylaHelsinki University Central HospitalCompleted
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more
-
Hoffmann-La RocheActive, not recruitingMetastatic Breast CancerKorea, Republic of, United Kingdom, Australia, China, Croatia, Finland, France, Norway, Portugal, Slovenia, Canada, Italy, Spain, Colombia, Brazil, Poland, United States, Greece, Turkey, Russian Federation, Philippines
-
Nektar TherapeuticsCompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Spain, Korea, Republic of, Canada, United Kingdom, Germany, France, Netherlands, Belgium, Italy, Russian Federation
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Finland, France, Hungary, Israel, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
European Organisation for Research and Treatment...TerminatedMetastatic CancerFrance, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
-
University of TurkuHoffmann-La RocheUnknown
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
Tampere University HospitalCompleted
-
University of NebraskaNational Cancer Institute (NCI)CompletedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Poland, Sweden, Italy
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPain | Breast Cancer | Prostate Cancer | Metastatic CancerUnited States, Canada
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
howard safranThe Miriam Hospital; Rhode Island HospitalTerminatedNSCLC | Lung Cancer | Metastatic Lung Cancer | Non-small Cell Lung CancerUnited States